AIDS/HIV was first seen in the early ’80s and ever since it killed over 25 million people. Nowadays the situation is not that bright as well. Close to 35 million people worldwide currently have the virus and as such a working vaccine against HIV would benefit the entire world.
Dr. Chil Yong Kang from Western’s School of Dentistry and Medicine together with his team are currently still working on the new HIV vaccine thanks to support offered by Sumagen Canada. The vaccine SAV001-H has been safely administrated to patients that reported no side effects after the injections. The Phase I clinical trials are indeed good news for the researchers. Phase II and Phase III clinical trials can begin but unfortunately commercial production will begin no sooner than 7 years.